Impact of external beam pelvic radiotherapy of endometrial carcinoma: A focus on chronic digestive toxicity.
Fiche publication
Date publication
février 2022
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier, Dr DEMOGEOT Nadine
Tous les auteurs :
Demogeot N, Salleron J, Beckendorf V, Peiffert D, Levitchi M, Charra-Brunaud C, Renard S
Lien Pubmed
Résumé
The standard treatment for endometrial cancer is surgery, although depending on the risk factors, adjuvant radiation therapy may also be given. It is proposed for high-risk carcinomas for which an improvement in progression-free survival though not overall survival has been shown. However, despite the development of radiotherapy treatments with intensity modulation and image guidance, adjuvant radiation therapy remains toxic to the digestive system. We aimed to investigate the incidence of digestive toxicity and the presence of any predictive factors.
Mots clés
Adjuvant radiotherapy, Cancer de l’endomètre, Digestive toxicity, Endometrial carcinoma, Radiothérapie adjuvante, Toxicité digestive
Référence
Cancer Radiother. 2022 Feb 13;: